Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab-Reference-Cited by-同舟云学术

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab

Published:2013-08-06 Issue:20 Volume:119 Page:3662-3671
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Evens Andrew M.¹,Vanderplas Ann²,LaCasce Ann S.³,Crosby Allison L.³,Nademanee Auayporn P.⁴,Kaminski Mark S.⁵,Abel Gregory A.³,Millenson Michael⁶,Czuczman Myron S.⁷,Rodriguez Maria A.⁸,Niland Joyce²,Zelenetz Andrew D.⁹,Gordon Leo I.¹⁰,Friedberg Jonathan W.¹¹

Affiliation:

1. Division of Hematology/Oncology; Tufts University School of Medicine; Boston Massachusetts

2. Department of Biostatistics; City of Hope National Medical Center; Duarte California

3. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

4. Department of Stem Cell Transplant; City of Hope National Medical Center; Duarte California

5. University of Michigan Cancer Center; Ann Arbor Michigan

6. Fox Chase Cancer Center; Philadelphia Pennsylvania

7. Roswell Park Cancer Institute; Buffalo New York

8. MD Anderson Cancer Center; Houston Texas

9. Memorial Sloan-Kettering Cancer Center; New York New York

10. Division of Hematology/Oncology; Northwestern University; Chicago Illinois

11. Division of Hematology/Oncology; University of Rochester, James P. Wilmot Cancer Center; Rochester New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28243/fullpdf

Reference25 articles.

1. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol;Brice;Ann Oncol,2000

2. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up;Rohatiner;J Clin Oncol,2007

3. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial;Schouten;J Clin Oncol,2003

4. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial;Horning;Blood,2001

5. Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis;Khabori;J Natl Cancer Inst,2012

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation;Transplantation and Cellular Therapy;2024-09

2. Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China;Frontiers in Oncology;2023-10-24

3. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma;Annals of Hematology;2023-10-18

4. Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis;BMC Cancer;2023-01-23

5. Efficacy of Autologous Hematopoietic Stem Cell Transplantation versus Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma: Systematic Review and Meta-Analysis;Oncology;2023